Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Australia needs better dermatological guidelines for gender-diverse patients.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Progesterone may help trans women with breast development and health, but more research is needed.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Gender-affirming dermatology treatments generally improve mental well-being for transgender individuals, but more research is needed.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Testosterone treatment may change estrogen receptor methylation in AFAB individuals.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Testosterone treatment may affect heart response to stress in transgender men.

Most transgender adolescents continued hormone treatment, with few stopping due to reasons other than returning to their birth gender.

Understanding sex and gender differences can improve personalized dermatology care.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Healthcare providers need better education and policies to serve transgender individuals effectively.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

Gender affirming hormone therapy improves outcomes in gender affirmation surgery.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.